In cancer cells, glucosamine has been reported as a substrate for protein O-GlcNAcylation by O-GlcNAc transferase (OGT) (17), and O-GlcNAcase (OGA) can remove the O-GlcNAc modification. The gene discussed is OGA; the disease is cancer.